CHRISTOPHER WAWRZUSIN: Open Payments
NPI 1710405030 · HORSEHEADS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 49 payments from 6 companies in 2025. Trend: 2023 $589 · 2024 $929 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $451 |
| ABBVIE INC. | 12 | $277 |
| Novo Nordisk Inc | 10 | $157 |
| PFIZER INC. | 3 | $56 |
| Amgen Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $27 |
Products named: VRAYLAR, AIRSUPRA, FARXIGA, Ozempic, NURTEC ODT, Cologuard Collection Kit, REPATHA, OTEZLA.
Industry payments across NY — which companies pay providers there.
